Brief: Nuvation Bio Q2 EPS USD -0.17
07/08/2025 12:30
Aug 07 (Reuters) - Nuvation Bio Q2 income from pperations USD -63.589 million. Q2 revenue USD 1.238 million vs. IBES estimate USD 357.1 thousand Q2 operating expenses USD 65.846 million Q2 pretax profit USD -59.007 million Q2 net income USD -59.007 million
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth